Table 4.
| |||
---|---|---|---|
Compound | R | Fold increase for EAAT2a |
|
4 h | 24 h | ||
1 | 2-Cl-6-F-Bn | nab | 2.0 ± 0.8 |
7–7 | 2-Cl-Bn | 2.1 ± 1.4 | 4.0 ± 0.3 |
7–18 | 3-Cl-Bn | 2.1 ± 0.3 | 4.1 ± 0.5 |
7–19 | 2,3-di-Cl-Bn | na | 2.4 ± 0.4 |
7–20 | 2,5-di-Cl-Bn | 1.4 ± 0.1 | 2.5 ± 0.4 |
7–21 | 2,4-di-Cl-Bn | 1.8 ± 0.5 | na |
7–22 | 2,6-di-Cl-Bn | 1.5 ± 0.8 | 3.9 ± 0.4 |
7–23 | 2-F-Bn | 2.2 ± 0.1 | 3.1 ± 0.2 |
7–24 | 4-F-Bn | 2.5 ± 0.6 | 2.6 ± 0.3 |
7–16 | 2,4-di-F-Bn | 2.4 ± 1.5 | 3.8 ± 0.8 |
7–25 | 2,6-di-F-Bn | 2.1 ± 1.4 | 2.2 ± 0.7 |
7–26 | 2,4,6-tri-F-Bn | 1.6 ± 1.0 | 2.4 ± 0.6 |
7–4 | 2-Me-Bn | 1.7 ± 0.1 | 3.5 ± 0.3 |
7–27 | 3-Me-Bn | 2.0 ± 0.2 | 2.8 ± 0.5 |
7–28 | 4-Me-Bn | 2.1 ± 1.1 | 2.6 ± 0.4 |
7–29 | 2,4-di-Me-Ph | 1.2 ± 0.3 | 2.2 ± 0.3 |
7–17 | 2,4-di-Me-Bn | 1.9 ± 0.8 | 6.4 ± 1.0 |
7–13 | 2,6-di-Me-Bn | na | 6.5 ± 1.0 |
7–30 | 2,4,6-tri-Me-Bn | 1.7 ± 0.3 | 4.7 ± 0.5 |
7–15 | 2-(2-Cl-6-F-phenylethyl) | 1.9 ± 0.7 | 6.7 ± 1.5 |
7–31 | 2-(2-Cl-phenylethyl) | 1.7 ± 0.2 | 4.8 ± 0.6 |
7–32 | 2-(2-Me-phenylethyl) | 1.2 ± 0.3 | 2.8 ± 0.4 |
7–33 | 1-(1,2,3,4-tetrahydronaphthalenyl) | na | 5.3 ± 1.1 |
7–14 | 1-(2-Cl-6-F-phenyl)ethyl | 1.7 ± 0.9 | 5.5 ± 1.0 |
7–34 | 2-Cl-4-F-Ph | 1.3 ± 0.1 | 2.5 ± 0.7 |
7–35 | 2-Cl-4-F-Bn | 1.6 ± 0.6 | 1.7 ± 0.4 |
7–12 | Bn | 1.3 ± 0.2 | 3.0 ± 0.5 |
7–36 | Et | 1.6 ± 0.7 | 1.9 ± 0.9 |
6–1 | H | na | 2.0 ± 0.8 |
Compound concentration of 10 μM;
na = not active